Bo Dai
- Hematology top 10%
-
- Epigenetics and DNA Methylation 4
- Congenital heart defects research 2
-
- Tissue Engineering and Regenerative Medicine 5
- Bladder and Urothelial Cancer Treatments 3
- Urinary and Genital Oncology Studies 3
-
- Cardiac Fibrosis and Remodeling 3
-
- Retinal Diseases and Treatments 2
-
- Renal Diseases and Glomerulopathies 2
- Co-authors
- Theodore P. RasmussenNamyoung JungRavindra MajetiAndrew J. GentlesAndrew P. FeinbergRonald W. MillardYigang WangWei Huang
- Cited by
- HematologyGeneticsMolecular Biology
- Journals
- Nature Communications (1 paper)Journal of the American College of Cardiology (1 paper)PLoS ONE (1 paper)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Bo Dai
29 papers receiving 540 citations
Peers
Comparison fields: 5 of 81
- Hematology 76
- Genetics 64
- Molecular Biology 319
- Cancer Research 55
- Biomaterials 41
Countries citing papers authored by Bo Dai
This map shows the geographic impact of Bo Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Dai more than expected).
Fields of papers citing papers by Bo Dai
This network shows the impact of papers produced by Bo Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Dai. The network helps show where Bo Dai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bo Dai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2022 | 3 | |
| 6 | 2021 | 3 | |
| 7 | 2019 | 16 | |
| 8 | 2018 | 8 | |
| 9 | 2018 | 18 | |
| 10 | 2018 | 5 | |
| 11 | 2016 | 5 | |
| 12 | 2015 | 105 | |
| 13 | 2013 | 18 | |
| 14 | 2012 | 11 | |
| 15 | 2011 | 4 | |
| 16 | 2011 | 47 | |
| 17 | 2011 | 12 | |
| 18 | 2011 | 50 | |
| 19 | 2010 | 1 | |
| 20 | 2009 | 1 |
About Bo Dai
Bo Dai is a scholar working on Nephrology, Transplantation and Surgery, having authored 34 papers that have together received 547 indexed citations. Recurring topics across this work include Tissue Engineering and Regenerative Medicine (5 papers), Epigenetics and DNA Methylation (4 papers), Bladder and Urothelial Cancer Treatments (3 papers), Cardiac Fibrosis and Remodeling (3 papers), Urinary and Genital Oncology Studies (3 papers), Retinal Diseases and Treatments (2 papers), Congenital heart defects research (2 papers) and Renal Diseases and Glomerulopathies (2 papers). The work is most often cited by research in Hematology (76 citations), Genetics (64 citations) and Molecular Biology (319 citations). Bo Dai has collaborated with scholars based in China, United States and India. Frequent co-authors include Theodore P. Rasmussen, Namyoung Jung, Ravindra Majeti, Andrew J. Gentles, Andrew P. Feinberg, Ronald W. Millard, Yigang Wang, Wei Huang, Muhammad Ashraf and Meifeng Xu. Their work appears in journals such as Nature Communications, Journal of the American College of Cardiology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.